Cargando…
Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in re...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725411/ https://www.ncbi.nlm.nih.gov/pubmed/29270409 http://dx.doi.org/10.3389/fcvm.2017.00079 |
_version_ | 1783285516099125248 |
---|---|
author | Miyazaki, Takuro Miyazaki, Akira |
author_facet | Miyazaki, Takuro Miyazaki, Akira |
author_sort | Miyazaki, Takuro |
collection | PubMed |
description | Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in response to vasoactive stimuli. However, it is also important to understand how normal blood vessels become defective and start degenerating. Growing evidence suggests that major protein catabolism pathways, including the ubiquitin-proteasome, autophagy, and calpain systems, are disturbed in atheroprone vessels and contribute to the pathogenesis of atherosclerosis. Indeed, dysregulation of ubiquitin–proteasome pathways results in the accumulation of defective proteins in blood vessels, leading to vascular endothelial dysfunction and apoptosis in affected cells. Impaired autophagy-lysosomal degradation affects smooth muscle cell transformation and proliferation, as well as endothelial integrity and phagocytic clearance of cellular corpses. Dysregulation of the calpain system confers proatherogenic properties to endothelial cells, smooth muscle cells, and macrophages. In this review article, we will discuss the current information available on defective protein catabolism in atheroprone vessels and its potential interrelation with inflammation-related signals. |
format | Online Article Text |
id | pubmed-5725411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57254112017-12-21 Defective Protein Catabolism in Atherosclerotic Vascular Inflammation Miyazaki, Takuro Miyazaki, Akira Front Cardiovasc Med Cardiovascular Medicine Vascular inflammation in atheroprone vessels propagates throughout the arterial tree in dyslipidemic patients, thereby accelerating atherosclerotic progression. To elucidate the mechanism of vascular inflammation, most previous studies have focused on inflammation-related signals that are sent in response to vasoactive stimuli. However, it is also important to understand how normal blood vessels become defective and start degenerating. Growing evidence suggests that major protein catabolism pathways, including the ubiquitin-proteasome, autophagy, and calpain systems, are disturbed in atheroprone vessels and contribute to the pathogenesis of atherosclerosis. Indeed, dysregulation of ubiquitin–proteasome pathways results in the accumulation of defective proteins in blood vessels, leading to vascular endothelial dysfunction and apoptosis in affected cells. Impaired autophagy-lysosomal degradation affects smooth muscle cell transformation and proliferation, as well as endothelial integrity and phagocytic clearance of cellular corpses. Dysregulation of the calpain system confers proatherogenic properties to endothelial cells, smooth muscle cells, and macrophages. In this review article, we will discuss the current information available on defective protein catabolism in atheroprone vessels and its potential interrelation with inflammation-related signals. Frontiers Media S.A. 2017-12-07 /pmc/articles/PMC5725411/ /pubmed/29270409 http://dx.doi.org/10.3389/fcvm.2017.00079 Text en Copyright © 2017 Miyazaki and Miyazaki. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Miyazaki, Takuro Miyazaki, Akira Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title_full | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title_fullStr | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title_full_unstemmed | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title_short | Defective Protein Catabolism in Atherosclerotic Vascular Inflammation |
title_sort | defective protein catabolism in atherosclerotic vascular inflammation |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725411/ https://www.ncbi.nlm.nih.gov/pubmed/29270409 http://dx.doi.org/10.3389/fcvm.2017.00079 |
work_keys_str_mv | AT miyazakitakuro defectiveproteincatabolisminatheroscleroticvascularinflammation AT miyazakiakira defectiveproteincatabolisminatheroscleroticvascularinflammation |